Clinical|trial reporting is on the rise

Clinical-trial reporting is on the rise - Nature

After nearly a decade of effort, the latest raw data suggest that reporting rates are improving. The website EU Trials Tracker, which records ...

Clinical-trial reporting is on the rise - PubMed

Clinical-trial reporting is on the rise. Nature. 2024 Oct;634(8034):S21-S23. doi: 10.1038/d41586-024-03317-1. Author.

Improving the reporting and interpretation of clinical trial outcomes

Not only is the volume of medical literature increasing, but the way in which reviews and clinical trials are being reported is becoming more complicated.

What clinical trial statistics tell us about the state of research today

... trial — but this requires a strategic approach to patient recruitment. The rise of decentralized clinical trials. The COVID-19 pandemic ...

Clinical trials are becoming more complex: a machine learning ...

(c) Correlation between Trial Complexity Score and phase 2 trial timelines. β is 2.85 therefore a 10 percentage point increase in the score ...

Increasing the Reporting Quality of Clinical Trials - JAMA Network

... increase the reporting quality of randomized trial protocols and reports. Submissions of protocols and result reports to 7 journals were ...

Clinical Trial Reporting Requirements - ClinicalTrials.gov

... research results available to the public if NIH supported the research. Sharing data increases transparency, allows others to use the data ...

Rethinking Clinical Trial Country Prioritization - IQVIA

This report sets out to characterize the need for clinical trial ... clinical trial complexity have been increasing. Combined with serial ...

Reporting on findings - World Health Organization (WHO)

Open consultation(Closed): WHO ICTRP guidance for reporting summary results in clinical trial registries ... reporting, and increase the value of clinical ...

Clinical Study Report Synopses | Pfizer

What were the important questions asked in the trial? What were the results? CSRs also include extensive details on the course of treatment for patients, the ...

US Federal Government Efforts to Improve Clinical Trial ...

Historically, patient advocates have led the movement to increase research transparency in the US. ... clinical trial reporting mandates [26]. For example ...

Clinical Trials Market SIZE, SHARE | GROWTH REPORT [2032]

Clinical trial success rates are majorly dependent on the stage of the study and the treatments or items being developed. In recent years, the number of ...

Clinical Trials Market Size, Share And Growth Report, 2030

Increasing innovation in clinical trial methods will drive the expanded access trials segment. Numerous oncology drugs are regularly ...

Trial Reporting in ClinicalTrials.gov — The Final Rule

The final rule for reporting clinical trial results has now been issued by the Department of Health and Human Services. It aims to increase ...

Guidelines for Reporting Trial Protocols and ... - JAMA Network

Modifications can also introduce biases, raising doubts about the validity of the conclusion of a clinical trial. COVID-19 has fundamentally ...

Clinical Trial Diversity and Representation - Amgen

Equitable access to clinical trials is integral to achieving health equity. RISE (Representation in ClInical ReSEarch) is a team at Amgen that is dedicated ...

Improving Representation in Clinical Trials and Research

There has been little progress in the last three decades to increase participation of racial and ethnic minority population groups.

Race/ethnicity reporting and representation in US clinical trials

The reporting of clinical trial enrollees' race/ethnicity is not ... While the increase in race/ethnicity reporting is encouraging, it ...

N-of-1 Trials, Their Reporting Guidelines, and the Advancement of ...

... trial design increases power (Schmid et al., 2014). This can allow ... clinical trial registries. 2.4. Outreach and Assessment. Outreach ...

A Comprehensive Guide to Clinical Trial Reporting | CRO

... trial protocols and clinical trial reports, respectively, to increase trial utility, replicability, and transparency. In addition, adherence ...